Clinical Trial Update: Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the feasibility and optimal sequencing of postoperative adjuvant FEC (fluorouracil, epirubicin, cyclophosphamide) followed by docetax…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DOCETAXEL (DOCETAXEL)
• Epirubicin (epirubicin)
• FLUOROURACIL (Fluorouracil)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED